In fact, its oncogenic effect is related to the complex NGAL/MMP-9 [11]; while its anti-tumor effect is related to the inhibition of the pro-neoplastic factor HIF-1a, the HIF-1a-dependent VEGF and FAK [16, 17]. Here, LCN2 is linked to neoplasm.